NCT06661148 - Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Chronic Hepatitis BHBV (Hepatitis B Virus)

Interventions

DRUG

EPI-003

Intravenous (IV) infusion.

Trial Locations (4)

Epigenic Therapeutics Investigational Site, Westmead

Epigenic Therapeutics Investigational Site, Hong Kong

Epigenic Therapeutics Investigational Site, Grafton

Epigenic Therapeutics Investigational Site, Christchurch